Wearables and Digital Biomarkers
Opal, a wearable single or multi-sensor device, collects objective precision motion analytics data. By using Opal to evaluate digital biomarkers, patients receive meaningful insights into disease diagnosis and progression and sponsors achieve more predictable, cost-effective and efficient trials.
REINVENTING CLINICAL ENDPOINT MEASUREMENT
Traditional methods of assessing movement disorders, such as clinical rating scales, are subjective and prone to human bias. While activity monitors like Fitbits and the Apple Watch provide objective data, the results are limited to activity tracking only. This data may not accurately capture the differences between patients and controls.
ERT’s complete wearable precision motion sensor solution overcomes these limitations. It delivers objective, high-frequency data combined with scientifically validated endpoints specific to your patient population.
When integrated with ERT’s data capture solutions for cardiac safety, eCOA, digital patient, imaging, or respiratory, whether in-clinic or virtually, Opal provides a holistic story of how a disease and therapy impacts patient function.
Adapts to patient needs
Opal can be worn on different locations of the body to adapt to the way a disease impacts patient movement.
Measures patient function
Opal measures more than activity level. It collects data on gait, balance, turning, and 100+ other endpoints.
Provides precision motion analytics
Opal collects precise data on patient movement in the clinic or at home.
Integrates with other solutions and devices
Opal can be used in conjunction with ERT’s data collection solutions and integrated with or be used alongside leading smartwatches and bands.
THE LARGEST DIGITAL ENDPOINT LIBRARY IN THE INDUSTRY
The patient is at the core of our endpoint development. All of the digital biomarkers/endpoints are both meaningful to the patient and measure patient function, which is also valuable for labeling to the sponsor.
The endpoints generated by Opal provide an objective measurement for monitoring disease progression or treatment efficacy. Sponsors can rely on our medical-grade technology and scientifically validated endpoints to lower risks and accelerate decision-making in their pipeline.
THE IMPACT OF WEARABLE SENSORS IN CLINICAL RESEARCH
WEARABLE TECHNOLOGY HAS THE POWER TO IMPROVE TRIALS
Earlier Go/ No-Go Decisions
Improved Precision of Motion Analysis
Meaningful Endpoints for Patients
This journal article shows that continuous monitoring of natural turning during daily activities inside or outside the home is feasible for patients with PD and the elderly.READ CASE STUDY
REQUEST A DEMO
ERT’s Wearables and Digital Biomarkers can integrate with the full suite of ERT products. Contact us today to learn how you can leverage these sensors in your clinical trial.